Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00927160 · ClinicalTrials.gov registry record
Evaluation of the Mobile Acute Care of the Elderly (MACE) Unit
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 346
- Enrollment target
NCT00927160: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT00927160 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 346 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00927160 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 346 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a new model of care, the Mobile Acute Care of the Elderly Unit is beneficial in improving patient outcomes for elderly patients admitted to the hospital.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 346 participants |
| Start Date | 2009-06 |
| Est. Completion | 2012-06 |
What the finished NCT00927160 record still lists
NCT00927160 is an observational study that tracks outcomes without assigning an intervention. The registered 346 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00927160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00927160 about?
NCT00927160 is a clinical study titled "Evaluation of the Mobile Acute Care of the Elderly (MACE) Unit". The purpose of this study is to determine if a new model of care, the Mobile Acute Care of the Elderly Unit is beneficial in improving patient outcomes for elderly patients admitted to the hospital.
What is the current status of trial NCT00927160?
This trial is currently completed. The enrollment target is 346 participants. The study started on 2009-06. Estimated completion is 2012-06.
Who is sponsoring clinical trial NCT00927160?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267886 · 346 participants · Phase 4
CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock
- NCT06705842 · 346 participants · Phase 4
APPI-Cost Trial for Perforated Appendicitis
- NCT06932887 · 346 participants · Phase 3
The Beat Pain Better Trial
- NCT01742143 · 347 participants
Impact of ICCAN on Cancer Treatment Completion and Quality of Life
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia